After a weak year for biotech stocks both in absolute and relative terms, 2022 could set up to be a much better year. The IBB etf could set up bullishly for 2022.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Δ